Retinal and choroidal neovascularization
Top Cited Papers
- 1 September 2000
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 184 (3) , 301-310
- https://doi.org/10.1002/1097-4652(200009)184:3<301::aid-jcp3>3.0.co;2-h
Abstract
The unique vascular supply of the retina, the ability to visualize the vasculature in vivo, and the ability to selectively express genes in the retina make the retina an ideal model system to study molecular mechanisms of angiogenesis. In addition, this area of investigation has great clinical significance, because retinal and choroidal neovascularization are the most common causes of severe visual loss in developed countries and new treatments are needed. As a result, interest in ocular neovascularization is rapidly growing and there has been considerable recent progress. Use of genetically engineered mice in recently developed murine models provides a means to investigate the role of individual gene products in neovascularization in two distinct vascular beds, the retinal vasculature and the choroidal vasculature. It appears that angiogenesis in different vascular beds has common themes, but also has tissue-specific aspects. This review summarizes recent progress in the field of ocular neovascularization and the prospects that it provides for the development of new treatments.Keywords
This publication has 81 references indexed in Scilit:
- Angiogenesis in Embryos and Ischemic DiseasesThrombosis and Haemostasis, 1997
- Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman PrimateArchives of Ophthalmology (1950), 1996
- Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proceedings of the National Academy of Sciences, 1995
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNature Medicine, 1995
- The Gene Structure of Tissue Inhibitor of Metalloproteinases (TIMP)-3 and Its Inhibitory Activities Define the Distinct TIMP Gene FamilyPublished by Elsevier ,1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Retinal Vascularization in Health and DiseaseAmerican Journal of Ophthalmology, 1957
- Role of Oxygen in the Genesis of Retrolental Fibroplasia: A Preliminary ReportBritish Journal of Ophthalmology, 1953